ACHE and Alzheimer disease: In addition, selective loss of acetylcholine-containing neurons in the brain contributes substantially to the cognitive decline in AD [5], and acetylcholinesterase (AChE) inhibitors modulating acetylcholine hydrolysis can increase the level and action duration of acetylcholine [6].